Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.74)
# 1,983
Out of 4,918 analysts
26
Total ratings
58.33%
Success rate
17.14%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $292.65 | +17.55% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $19.88 | +169.11% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $28.72 | +39.28% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $19.48 | +54.00% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.39 | +93.62% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $11.26 | +42.10% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.55 | +41,900.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $340 → $460 | $2.85 | +16,040.35% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.22 | +1,483.85% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $12.05 | +32.78% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.16 | +1,324.05% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $292.65
Upside: +17.55%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $19.88
Upside: +169.11%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $28.72
Upside: +39.28%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $19.48
Upside: +54.00%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.39
Upside: +93.62%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $11.26
Upside: +42.10%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.55
Upside: +41,900.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $340 → $460
Current: $2.85
Upside: +16,040.35%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.22
Upside: +1,483.85%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $12.05
Upside: +32.78%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.16
Upside: +1,324.05%